| |
| |
|
| Insider
Information: |
Stuart Iain |
| Relationship: |
|
| City: |
Rehovot |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
133,741 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$29,891 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
133,741 |
|
|
| Total
Value |
$29,891 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foamix Pharmaceuticals Ltd |
FOMX |
Chief Scientific Officer |
2020-03-09 |
0 |
2018-08-08 |
0 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
|
2024-04-01 |
133,741 |
2020-03-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYNE |
VYNE Therapeutics Inc |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-04-01 |
4 |
D |
$3.08 |
$484 |
D/D |
(157) |
133,741 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2024-01-02 |
4 |
D |
$2.28 |
$358 |
D/D |
(157) |
133,898 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
134,055 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
71,555 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-10-02 |
4 |
D |
$3.83 |
$4,535 |
D/D |
(1,184) |
9,055 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-06-30 |
4 |
D |
$4.10 |
$619 |
D/D |
(151) |
10,239 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-12-31 |
4 |
D |
$0.15 |
$258 |
D/D |
(1,720) |
220,252 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-09-30 |
4 |
D |
$0.22 |
$383 |
D/D |
(1,719) |
221,972 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-06-30 |
4 |
D |
$0.39 |
$669 |
D/D |
(1,719) |
223,691 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-03-31 |
4 |
D |
$0.65 |
$2,255 |
D/D |
(3,469) |
225,410 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
228,879 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-12-31 |
4 |
D |
$1.02 |
$1,275 |
D/D |
(1,250) |
153,879 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-09-30 |
4 |
D |
$1.39 |
$2,057 |
D/D |
(1,480) |
155,129 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
60,859 |
156,609 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-06-30 |
4 |
D |
$3.51 |
$10,821 |
D/D |
(3,083) |
95,750 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-03-31 |
4 |
D |
$6.84 |
$13,304 |
D/D |
(1,945) |
98,833 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
29,213 |
100,778 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-12-31 |
4 |
D |
$1.58 |
$3,757 |
D/D |
(2,378) |
286,262 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-09-30 |
4 |
D |
$1.66 |
$3,947 |
D/D |
(2,378) |
288,640 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-06-30 |
4 |
D |
$1.73 |
$4,114 |
D/D |
(2,378) |
291,018 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
112,500 |
293,401 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-04-06 |
4 |
D |
$1.40 |
$5,268 |
D/D |
(3,763) |
180,901 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
125,212 |
184,664 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-03-31 |
4 |
D |
$2.68 |
$5,199 |
D/D |
(1,940) |
59,452 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
61,392 |
61,392 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
